69 Adipositastherapie bei Kindern und Jugendlichen in der COVID19-Pandemie: Daten aus der Adipositas-Patienten-Verlaufsdokumentation (APV)
Angela Galler(University Hospital Leipzig), Reinhard W. Holl(Deutsches Diabetes-Zentrum e.V.), Sabine Linke, Susanna Wiegand(Charité - Universitätsmedizin Berlin), Petra Warschburger(University of Potsdam), Almut Dannemann(Humboldt-Universität zu Berlin), Daniel Weghuber, Robert Stein(Cleveland Clinic), Susann Blüher(Beth Israel Deaconess Medical Center), Anna Wagner(University of Augsburg), Ines Gellhaus, Markus Röbl, Thomas Kapellen(University Hospital Leipzig), G. Schauerte
Cited by 0
Related Papers
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
|New England Journal of Medicine|2016|480
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
|Journal of the American College of Cardiology|2018|465
Gender Differences of Adiponectin Levels Develop during the Progression of Puberty and Are Related to Serum Androgen Levels
|The Journal of Clinical Endocrinology & Metabolism|2004|458
Body Fat Mass and Macronutrient Intake in Relation to Circulating Soluble Leptin Receptor, Free Leptin Index, Adiponectin, and Resistin Concentrations in Healthy Humans
|The Journal of Clinical Endocrinology & Metabolism|2003|430